Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Metastatic Castration-resistant Prostate Cancer (mCRPC) × PSMA-11 × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1

Interventions

radium Ra 223 dichloride 2 pembrolizumab 2 enzalutamide 2 abiraterone 2 Injections 2 Abiraterone Acetate 2 niraparib 1 efineptakin alfa 1 darolutamide 1 capivasertib 1 cabazitaxel 1 apalutamide 1 Solutions 1 Radium-223 1 Prednisone 1 Pluvicto 1 PSMA-11 1 Lutetium-177 1 Lutetium 1 Docetaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04825652 2023-01-13

177Lu-PSMA-617 Managed Access Program for mCRPC Patients

Advanced Accelerator Applications

No longer available

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡